We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Chromatrap® Enriches Epigenetic Marks from Primary Cells
Product News

Chromatrap® Enriches Epigenetic Marks from Primary Cells

Chromatrap® Enriches Epigenetic Marks from Primary Cells
Product News

Chromatrap® Enriches Epigenetic Marks from Primary Cells


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Chromatrap® Enriches Epigenetic Marks from Primary Cells"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

A new application note from Porvair Sciences details a protocol for its Chromatrap® ChIP assay kit that has been developed to enrich epigenetic marks from primary human tissue cells.

Chromatrap® Pro-A, the novel solid-based matrix for chromatin immunoprecipitation assays (ChIP) has been successfully used for isolation of high quality chromatin from difficult biopsy material.

Focusing on an application to precipitate epigenetic marks from primary endometrial stromal cells - results show high abundant epigenetic marks from 1 million cells isolated from a tissue biopsy, with selective amplification of positive gene targets relative to negative IgG and negative gene loci.

Not only is Chromatrap proven to produce positive amplification of histone regulatory marks at specific gene loci but also the novel ChIP assay kit is shown to be compatible with human tissue.

Advertisement